Lipotoxicity in type 2 diabetic cardiomyopathy

Cardiovascular Research

Volumn 92, Issue 1, 2011, Pages 10-18

  Van De Weijer, Tineke ^a   Schrauwen Hinderling, Vera B ^a   Schrauwen, Patrick ^a  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Diabetes; Diabetic cardiomyopathy; Lipid accumulation; Lipotoxicity; Mitochondria

Indexed keywords

CERAMIDE; DIACYLGLYCEROL; FATTY ACID TRANSPORTER; PALMITIC ACID; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; DIABETIC CARDIOMYOPATHY; ENDOPLASMIC RETICULUM STRESS; ENERGY TRANSFER; FATTY ACID TRANSPORT; HEART FUNCTION; HUMAN; ISCHEMIC HEART DISEASE; LIPID STORAGE; LIPID TRANSPORT; LIPOTOXICITY; MEMBRANE STABILIZATION; METABOLIC DISORDER; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE PHOSPHORYLATION UNCOUPLING; PRIORITY JOURNAL; REVIEW; STEATOSIS; UPREGULATION;

ADENOSINE TRIPHOSPHATE; APOPTOSIS; CARDIOMYOPATHIES; CERAMIDES; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; HUMANS; LIPID METABOLISM; MYOCARDIUM; REACTIVE OXYGEN SPECIES;

EID: 80052914149     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr212     Document Type: Review

References (126)

1. Garcia MJ, McNamara PM, Gordon T, Kannel WB. Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. Diabetes 1974; 23:105-111.
2. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-234. (Pubitemid 28350165)
3. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol 1972;30: 595-602.
4. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: the Framingham study. Am J Cardiol 1974;34:29-34.
5. Fein FS, Sonnenblick EH. Diabetic cardiomyopathy. Prog Cardiovasc Dis 1985;27: 255-270. (Pubitemid 15158896)
6. Unger RH. Lipotoxicity in the pathogenesis of obesity-dependent NIDDM. Genetic and clinical implications. Diabetes 1995;44:863-870.
7. Liu JE, Palmieri V, Roman MJ, Bella JN, Fabsitz R, Howard BV et al. The impact of diabetes on left ventricular filling pattern in normotensive and hypertensive adults: the Strong Heart Study. J Am Coll Cardiol 2001;37:1943-1949. (Pubitemid 32499984)
8. Bell DS. Diabetic cardiomyopathy. Diabetes Care 2003;26:2949-2951. (Pubitemid 37205574)
9. Poirier P, Bogaty P, Garneau C, Marois L, Dumesnil JG. Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy. Diabetes Care 2001;24:5-10. (Pubitemid 32104211)
10. Zabalgoitia M, Ismaeil MF, Anderson L, Maklady FA. Prevalence of diastolic dysfunction in normotensive, asymptomatic patients with well-controlled type 2 diabetes mellitus. Am J Cardiol 2001;87:320-323. (Pubitemid 32144874)
11. McGavock JM, Lingvay I, Zib I, Tillery T, Salas N, Unger R et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 2007; 116:1170-1175. (Pubitemid 47360218)
12. McGavock JM, Victor RG, Unger RH, Szczepaniak LS. Adiposity of the heart, revisited. Ann Intern Med 2006;144:517-524. (Pubitemid 46780675)
13. Singh S, Dhingra S, Ramdath DD, Vasdev S, Gill V, Singal PK. Risk factors preceding type 2 diabetes and cardiomyopathy. J Cardiovasc Transl Res 2010;3:580-596.
14. Despres JP, Lemieux I, Bergeron J, Pibarot P, Mathieu P, Larose E et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008;28:1039-1049.
15. Lakka TA, Bouchard C. Physical activity, obesity and cardiovascular diseases. Handb Exp Pharmacol 2005:137-163.
16. Boden G. Obesity, insulin resistance and free fatty acids. Curr Opin Endocrinol Diabetes Obes 2011;18:139-143.
17. Spector KS. Diabetic cardiomyopathy. Clin Cardiol 1998;21:885-887. (Pubitemid 28559694)
18. Boudina S, Abel ED. Diabetic cardiomyopathy revisited. Circulation 2007;115: 3213-3223.
19. Lopaschuk GD. Abnormal mechanical function in diabetes: relationship to altered myocardial carbohydrate/lipid metabolism. Coron Artery Dis 1996;7:116-123. (Pubitemid 26256417)
20. Rijzewijk LJ, van der Meer RW, Lamb HJ, de Jong HW, Lubberink M, Romijn JA et al. Altered myocardial substrate metabolism and decreased diastolic function in nonischemic human diabetic cardiomyopathy: studies with cardiac positron emission tomography and magnetic resonance imaging. J Am Coll Cardiol 2009;54:1524-1532.
21. Anderson EJ, Kypson AP, Rodriguez E, Anderson CA, Lehr EJ, Neufer PD. Substratespecific derangements in mitochondrial metabolism and redox balance in the atrium of the type 2 diabetic human heart. J Am Coll Cardiol 2009;54:1891-1898.
22. Normand-Lauziere F, Frisch F, Labbe SM, Bherer P, Gagnon R, Cunnane SC et al. Increased postprandial nonesterified fatty acid appearance and oxidation in type 2 diabetes is not fully established in offspring of diabetic subjects. PLoS One 2010;5: e10956.
23. Il'yasova D, Wang F, D'Agostino RB Jr, Hanley A, Wagenknecht LE. Prospective association between fasting NEFA and type 2 diabetes: impact of post-load glucose. Diabetologia 2010;53:866-874.
24. Cusi K. The role of adipose tissue and lipotoxicity in the pathogenesis of type 2 diabetes. Curr Diab Rep 10:306-315.
25. Lionetti L, Mollica MP, Lombardi A, Cavaliere G, Gifuni G, Barletta A. From chronic overnutrition to insulin resistance: the role of fat-storing capacity and inflammation. Nutr Metab Cardiovasc Dis 2009;19:146-152.
26. Szczepaniak LS, Dobbins RL, Metzger GJ, Sartoni-D'Ambrosia G, Arbique D, Vongpatanasin W et al. Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magn Reson Med 2003;49:417-423. (Pubitemid 36262808)
27. Sharma S, Adrogue JV, Golfman L, Uray I, Lemm J, Youker K et al. Intramyocardial lipid accumulation in the failing human heart resembles the lipotoxic rat heart. Faseb J 2004;18:1692-1700. (Pubitemid 39463708)
28. Kankaanpaa M, Lehto HR, Parkka JP, Komu M, Viljanen A, Ferrannini E et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 2006;91: 4689-4695. (Pubitemid 44833458)
29. Christoffersen C, Bollano E, Lindegaard ML, Bartels ED, Goetze JP, Andersen CB et al. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 2003;144:3483-3490. (Pubitemid 36904426)
30. Hammer S, van der Meer RW, Lamb HJ, Schar M, de Roos A, Smit JW et al. Progressive caloric restriction induces dose-dependent changes in myocardial triglyceride content and diastolic function in healthy men. J Clin Endocrinol Metab 2008;93: 497-503. (Pubitemid 351240822)
31. Bilet L, van de Weijer T, Hesselink MK, Glatz JF, Lamb HJ, Wildberger J et al. Exercise-induced modulation of cardiac lipid content in healthy lean young men. Basic Res Cardiol 2011;106:307-315.
32. Hamilton JA, GuoW, Kamp F. Mechanism of cellular uptake of long-chain fatty acids: do we need cellular proteins? Mol Cell Biochem 2002;239:17-23. (Pubitemid 35385791)
33. Sprong H, van der Sluijs P, van Meer G. How proteins move lipids and lipids move proteins. Nat Rev Mol Cell Biol 2001;2:504-513. (Pubitemid 33673400)
34. Glatz JF, Luiken JJ, Bonen A. Membrane fatty acid transporters as regulators of lipid metabolism: implications for metabolic disease. Physiol Rev 2010;90:367-417.
35. Luiken JJ, Turcotte LP, Bonen A. Protein-mediated palmitate uptake and expression of fatty acid transport proteins in heart giant vesicles. J Lipid Res 1999;40:1007-1016. (Pubitemid 29287871)
36. Luiken JJ, Coort SL, Willems J, Coumans WA, Bonen A, van der Vusse GJ et al. Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. Diabetes 2003; 52:1627-1634. (Pubitemid 36792449)
37. Bonen A, Campbell SE, Benton CR, Chabowski A, Coort SL, Han XX et al. Regulation of fatty acid transport by fatty acid translocase/CD36. Proc Nutr Soc 2004; 63:245-249. (Pubitemid 38787473)
38. Ibrahimi A, Bonen A, Blinn WD, Hajri T, Li X, Zhong K et al. Muscle-specific overexpression of FAT/CD36 enhances fatty acid oxidation by contracting muscle, reduces plasma triglycerides and fatty acids, and increases plasma glucose and insulin. J Biol Chem 1999;274:26761-26766.
39. Luiken JJ, Coort SL, Willems J, CoumansWA, Bonen A, Glatz JF. Dipyridamole alters cardiac substrate preference by inducing translocation of FAT/CD36, but not that of GLUT4. Mol Pharmacol 2004;65:639-645. (Pubitemid 38264031)
40. Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiol Rev 2010;90:207-258.
41. Coort SL, Hasselbaink DM, Koonen DP, Willems J, Coumans WA, Chabowski A et al. Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese zucker rats. Diabetes 2004;53:1655-1663. (Pubitemid 38857021)
42. Coort SL, Luiken JJ, van der Vusse GJ, Bonen A, Glatz JF. Increased FAT (fatty acid translocase)/CD36-mediated long-chain fatty acid uptake in cardiac myocytes from obese Zucker rats. Biochem Soc Trans 2004;32:83-85. (Pubitemid 38283019)
43. Carley AN, Severson DL. Fatty acid metabolism is enhanced in type 2 diabetic hearts. Biochim Biophys Acta 2005;1734:112-126. (Pubitemid 40724778)
44. Chiu HC, Kovacs A, Blanton RM, Han X, Courtois M, Weinheimer CJ et al. Transgenic expression of fatty acid transport protein 1 in the heart causes lipotoxic cardiomyopathy. Circ Res 2005;96:225-233. (Pubitemid 40209370)
45. Nickerson JG, Momken I, Benton CR, Lally J, Holloway GP, Han XX et al. Proteinmediated fatty acid uptake: regulation by contraction, AMP-activated protein kinase, and endocrine signals. Appl Physiol Nutr Metab 2007;32:865-873.
46. Nickerson JG, Alkhateeb H, Benton CR, Lally J, Nickerson J, Han XX et al. Greater transport efficiencies of the membrane fatty acid transporters FAT/CD36 and FATP4 compared with FABPpm and FATP1 and differential effects on fatty acid esterification and oxidation in rat skeletal muscle. J Biol Chem 2009;284: 16522-16530.
47. Gimeno RE, Ortegon AM, Patel S, Punreddy S, Ge P, Sun Y et al. Characterization of a heart-specific fatty acid transport protein. J Biol Chem 2003;278:16039-16044. (Pubitemid 36799724)
48. Lavrentyev EN, He D, Cook GA. Expression of genes participating in regulation of fatty acid and glucose utilization and energy metabolism in developing rat hearts. Am J Physiol Heart Circ Physiol 2004;287:H2035-H2042. (Pubitemid 39430741)
49. DiRusso CC, Li H, Darwis D, Watkins PA, Berger J, Black PN. Comparative biochemical studies of the murine fatty acid transport proteins (FATP) expressed in yeast. J Biol Chem 2005;280:16829-16837. (Pubitemid 41397967)
50. Schoonderwoerd K, Broekhoven-Schokker S, Hulsmann WC, Stam H. Properties of phosphatidate phosphohydrolase and diacylglycerol acyltransferase activities in the isolated rat heart. Effect of glucagon, ischaemia and diabetes. Biochem J 1990;268: 487-492. (Pubitemid 20193993)
51. Lewin TM, de Jong H, Schwerbrock NJ, Hammond LE, Watkins SM, Combs TP et al. Mice deficient in mitochondrial glycerol-3-phosphate acyltransferase-1 have diminished myocardial triacylglycerol accumulation during lipogenic diet and altered phospholipid fatty acid composition. Biochim Biophys Acta 2008;1781:352-358.
52. Atkinson LL, Kozak R, Kelly SE, Onay Besikci A, Russell JC, Lopaschuk GD. Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulinresistant rats. Am J Physiol Endocrinol Metab 2003;284:E923-E930. (Pubitemid 36444027)
53. Glenn DJ, Wang F, Nishimoto M, Cruz MC, Uchida Y, Holleran WM et al. A murine model of isolated cardiac steatosis leads to cardiomyopathy. Hypertension 2011;57: 216-222.
54. Liu L, Shi X, Bharadwaj KG, Ikeda S, Yamashita H, Yagyu H et al. DGAT1 expression increases heart triglyceride content but ameliorates lipotoxicity. J Biol Chem 2009; 284:36312-36323.
55. Ueno M, Suzuki J, Zenimaru Y, Takahashi S, Koizumi T, Noriki S et al. Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice. Am J Physiol Endocrinol Metab 2008;294:E1109-E1118.
56. Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science 2006;312:734-737.
57. Lass A, Zimmermann R, Oberer M, Zechner R. Lipolysis-a highly regulated multienzyme complex mediates the catabolism of cellular fat stores. Prog Lipid Res 2011; 50:14-27.
58. Fischer J, Lefevre C, Morava E, Mussini JM, Laforet P, Negre-Salvayre A et al. The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy. Nat Genet 2007;39:28-30. (Pubitemid 46026498)
59. Belke DD, Larsen TS, Gibbs EM, Severson DL. Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice. Am J Physiol Endocrinol Metab 2000;279:E1104-E1113.
60. Isenberg G, Han S, Schiefer A, Wendt-Gallitelli MF. Changes in mitochondrial calcium concentration during the cardiac contraction cycle. Cardiovasc Res 1993; 27:1800-1809. (Pubitemid 23337873)
61. Wu P, Peters JM, Harris RA. Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor alpha. Biochem Biophys Res Commun 2001;287:391-396. (Pubitemid 32917610)
62. Chatham JC, Forder JR. Metabolic compartmentation of lactate in the glucoseperfused rat heart. Am J Physiol 1996;270:H224-H229.
63. Boudina S, Sena S, Theobald H, Sheng X, Wright JJ, Hu XX et al. Mitochondrial energetics in the heart in obesity-related diabetes: direct evidence for increased uncoupled respiration and activation of uncoupling proteins. Diabetes 2007;56: 2457-2466. (Pubitemid 47523253)
64. Lopaschuk GD, Spafford M. Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats. Circ Res 1989;65:378-387. (Pubitemid 19194624)
65. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-789.
66. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A et al. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest 2002;109:121-130. (Pubitemid 34052548)
67. Young ME, Patil S, Ying J, Depre C, Ahuja HS, Shipley GL et al. Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart. Faseb J 2001;15:833-845. (Pubitemid 32246002)
68. Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D et al. Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci USA 2000;97:1784-1789. (Pubitemid 30118520)
69. Marfella R, Di Filippo C, Portoghese M, Barbieri M, Ferraraccio F, Siniscalchi M et al. Myocardial lipid accumulation in patients with pressure-overloaded heart and metabolic syndrome. J Lipid Res 2009;50:2314-2323.
70. Dewald O, Sharma S, Adrogue J, Salazar R, Duerr GD, Crapo JD et al. Downregulation of peroxisome proliferator-activated receptor-alpha gene expression in a mouse model of ischemic cardiomyopathy is dependent on reactive oxygen species and prevents lipotoxicity. Circulation 2005;112:407-415. (Pubitemid 41022083)
71. Nuutila P, Koivisto VA, Knuuti J, Ruotsalainen U, Teras M, Haaparanta M et al. Glucose-free fatty acid cycle operates in human heart and skeletal muscle in vivo. J Clin Invest 1992;89:1767-1774.
72. Zachara NE, Hart GW. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta 2004;1673:13-28. (Pubitemid 38844791)
73. Wells L, Hart GW. O-GlcNAc turns twenty: functional implications for posttranslational modification of nuclear and cytosolic proteins with a sugar. FEBS Lett 2003;546:154-158. (Pubitemid 36782297)
74. Rajamani U, Essop MF. Hyperglycemia-mediated activation of the hexosamine biosynthetic pathway results in myocardial apoptosis. Am J Physiol Cell Physiol 299: C139-C147.
75. Stanley WC, Lopaschuk GD, McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovasc Res 1997;34:25-33. (Pubitemid 27261909)
76. Paulson DJ. The diabetic heart is more sensitive to ischemic injury. Cardiovasc Res 1997;34:104-112. (Pubitemid 27261918)
77. Opie LH. The metabolic vicious cycle in heart failure. Lancet 2004;364:1733-1734. (Pubitemid 39488043)
78. Burkhoff D, Weiss RG, Schulman SP, Kalil-Filho R, Wannenburg T, Gerstenblith G. Influence of metabolic substrate on rat heart function and metabolism at different coronary flows. Am J Physiol 1991;261:H741-H750.
79. Liu Q, Docherty JC, Rendell JC, Clanachan AS, Lopaschuk GD. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation. J Am Coll Cardiol 2002;39:718-725. (Pubitemid 34158171)
80. Taegtmeyer H, McNulty P, Young ME. Adaptation and maladaptation of the heart in diabetes: Part I: general concepts. Circulation 2002;105:1727-1733. (Pubitemid 34298619)
81. Boehm EA, Jones BE, Radda GK, Veech RL, Clarke K. Increased uncoupling proteins and decreased efficiency in palmitate-perfused hyperthyroid rat heart. Am J Physiol Heart Circ Physiol 2001;280:H977-H983.
82. Murray AJ, Anderson RE, Watson GC, Radda GK, Clarke K. Uncoupling proteins in human heart. Lancet 2004;364:1786-1788. (Pubitemid 39488064)
83. Schrauwen P, Saris WH, Hesselink MK. An alternative function for human uncoupling protein 3: protection of mitochondria against accumulation of nonesterified fatty acids inside the mitochondrial matrix. Faseb J 2001;15:2497-2502. (Pubitemid 33063178)
84. Tune JD, Yeh C, Setty S, Downey HF. ATP-dependent K(+) channels contribute to local metabolic coronary vasodilation in experimental diabetes. Diabetes 2002;51: 1201-1207. (Pubitemid 34438369)
85. Wojtczak L, Schonfeld P. Effect of fatty acids on energy coupling processes in mitochondria. Biochim Biophys Acta 1993;1183:41-57. (Pubitemid 23322954)
86. Samartsev VN, Smirnov AV, Zeldi IP, Markova OV, Mokhova EN, Skulachev VP. Involvement of aspartate/glutamate antiporter in fatty acid-induced uncoupling of liver mitochondria. Biochim Biophys Acta 1997;1319:251-257. (Pubitemid 27156896)
87. Skulachev VP. Membrane-linked systems preventing superoxide formation. Biosci Rep 1997;17:347-366. (Pubitemid 27466758)
88. Starkov AA. 'Mild' uncoupling of mitochondria. Biosci Rep 1997;17:273-279.
89. Knuuti J, Takala TO, Nagren K, Sipila H, Turpeinen AK, Uusitupa MI et al. Myocardial fatty acid oxidation in patients with impaired glucose tolerance. Diabetologia 2001;44: 184-187. (Pubitemid 32156202)
90. Veerappan RM, Senthil S, Rao MR, Ravikumar R, Pugalendi KV. Redox status and lipid peroxidation in alcoholic hypertensive patients and alcoholic hypertensive patients with diabetes. Clin Chim Acta 2004;340:207-212. (Pubitemid 38167526)
91. Cimbaljevic B, Vasilijevic A, Cimbaljevic S, Buzadzic B, Korac A, Petrovic V et al. Interrelationship of antioxidative status, lipid peroxidation, and lipid profile in insulindependent and non-insulin-dependent diabetic patients. Can J Physiol Pharmacol 2007; 85:997-1003.
92. Song Y, Du Y, Prabhu SD, Epstein PN. Diabetic cardiomyopathy in OVE26 mice shows mitochondrial ROS production and divergence between in vivo and in vitro contractility. Rev Diabet Stud 2007;4:159-168.
93. Boudina S, Sena S, O'Neill BT, Tathireddy P, Young ME, Abel ED. Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 2005;112:2686-2695. (Pubitemid 41532606)
94. Lin J, Yang R, Tarr PT, Wu PH, Handschin C, Li S et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 2005;120:261-273. (Pubitemid 40174768)
95. Boudina S, Bugger H, Sena S, O'Neill BT, Zaha VG, Ilkun O et al. Contribution of impaired myocardial insulin signaling to mitochondrial dysfunction and oxidative stress in the heart. Circulation 2009;119:1272-1283.
96. Tanaka Y, Konno N, Kako KJ. Mitochondrial dysfunction observed in situ in cardiomyocytes of rats in experimental diabetes. Cardiovasc Res 1992;26:409-414.
97. How OJ, Aasum E, Severson DL, Chan WY, Essop MF, Larsen TS. Increased myocardial oxygen consumption reduces cardiac efficiency in diabetic mice. Diabetes 2006;55:466-473. (Pubitemid 43343277)
98. How OJ, Aasum E, Kunnathu S, Severson DL, Myhre ES, Larsen TS. Influence of substrate supply on cardiac efficiency, as measured by pressure-volume analysis in ex vivo mouse hearts. Am J Physiol Heart Circ Physiol 2005;288:H2979-H2985. (Pubitemid 40720683)
99. Scheuermann-Freestone M, Madsen PL, Manners D, Blamire AM, Buckingham RE, Styles P et al. Abnormal cardiac and skeletal muscle energy metabolism in patients with type 2 diabetes. Circulation 2003;107:3040-3046. (Pubitemid 36758977)
100. Diamant M, Lamb HJ, Groeneveld Y, Endert EL, Smit JW, Bax JJ et al. Diastolic dysfunction is associated with altered myocardial metabolism in asymptomatic normotensive patients with well-controlled type 2 diabetes mellitus. J Am Coll Cardiol 2003; 42:328-335. (Pubitemid 36851426)
101. Nakae I, Mitsunami K, Yoshino T, Omura T, Tsutamoto T, Matsumoto T et al. Clinical features of myocardial triglyceride in different types of cardiomyopathy assessed by proton magnetic resonance spectroscopy: comparison with myocardial creatine. J Card Fail 2010;16:812-822.
102. van der Meer RW, Rijzewijk LJ, de Jong HW, Lamb HJ, Lubberink M, Romijn JA et al. Pioglitazone improves cardiac function and alters myocardial substrate metabolism without affecting cardiac triglyceride accumulation and high-energy phosphate metabolism in patients with well-controlled type 2 diabetes mellitus. Circulation 2009;119:2069-2077.
103. Balaban RS. Cardiac energy metabolism homeostasis: role of cytosolic calcium. J Mol Cell Cardiol 2002;34:1259-1271. (Pubitemid 35244399)
104. Belke DD, Swanson EA, Dillmann WH. Decreased sarcoplasmic reticulum activity and contractility in diabetic db/db mouse heart. Diabetes 2004;53:3201-3208. (Pubitemid 39564496)
105. Dong F, Zhang X, Yang X, Esberg LB, Yang H, Zhang Z et al. Impaired cardiac contractile function in ventricular myocytes from leptin-deficient ob/ob obese mice. J Endocrinol 2006;188:25-36. (Pubitemid 43159807)
106. Fauconnier J, Lanner JT, Zhang SJ, Tavi P, Bruton JD, Katz A et al. Insulin and inositol 1,4,5-trisphosphate trigger abnormal cytosolic Ca2+ transients and reveal mitochondrial Ca2+ handling defects in cardiomyocytes of ob/ob mice. Diabetes 2005; 54:2375-2381. (Pubitemid 41134265)
107. Relling DP, Esberg LB, Fang CX, Johnson WT, Murphy EJ, Carlson EC et al. High-fat diet-induced juvenile obesity leads to cardiomyocyte dysfunction and upregulation of Foxo3a transcription factor independent of lipotoxicity and apoptosis. J Hypertens 2006;24:549-561. (Pubitemid 43261920)
108. de Vries JE, Vork MM, Roemen TH, de Jong YF, Cleutjens JP, van der Vusse GJ et al. Saturated but not mono-unsaturated fatty acids induce apoptotic cell death in neonatal rat ventricular myocytes. J Lipid Res 1997;38:1384-1394. (Pubitemid 27332565)
109. Listenberger LL, Ory DS, Schaffer JE. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J Biol Chem 2001;276:14890-14895.
110. Miller TA, LeBrasseur NK, Cote GM, Trucillo MP, Pimentel DR, Ido Y et al. Oleate prevents palmitate-induced cytotoxic stress in cardiac myocytes. Biochem Biophys Res Commun 2005;336:309-315. (Pubitemid 41253435)
111. Bick RJ, Wood DE, Poindexter B, McMillin JB, Karoly A, Wang D et al. Cytokines increase neonatal cardiac myocyte calcium concentrations: the involvement of nitric oxide and cyclic nucleotides. J Interferon Cytokine Res 1999;19:645-653. (Pubitemid 29331318)
112. Hickson-Bick DL, Buja LM, McMillin JB. Palmitate-mediated alterations in the fatty acid metabolism of rat neonatal cardiac myocytes. J Mol Cell Cardiol 2000;32: 511-519.
113. Park TS, Hu Y, Noh HL, Drosatos K, Okajima K, Buchanan J et al. Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res 2008;49:2101-2112.
114. Baranowski M, Blachnio-Zabielska A, Hirnle T, Harasiuk D, Matlak K, Knapp M et al. Myocardium of type 2 diabetic and obese patients is characterized by alterations in sphingolipid metabolic enzymes but not by accumulation of ceramide. J Lipid Res 2010;51:74-80.
115. van Herpen NA, Schrauwen-Hinderling VB. Lipid accumulation in non-adipose tissue and lipotoxicity. Physiol Behav 2008;94:231-241. (Pubitemid 351615422)
116. Zhang L, Ussher JR, Oka T, Cadete VJ, Wagg C, Lopaschuk GD. Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired Insulin-stimulated glucose oxidation. Cardiovasc Res 2011;89:148-156.
117. Karaskov E, Scott C, Zhang L, Teodoro T, Ravazzola M, Volchuk A. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology 2006;147:3398-3407. (Pubitemid 43901131)
118. Ron D, Walter P. Signal integration in the endoplasmic reticulum unfolded protein response. Nat Rev Mol Cell Biol 2007;8:519-529. (Pubitemid 46985379)
119. Szegezdi E, Logue SE, Gorman AM, Samali A. Mediators of endoplasmic reticulum stress-induced apoptosis. EMBO Rep 2006;7:880-885. (Pubitemid 44523966)
120. Dong F, Ren J. Adiponectin improves cardiomyocyte contractile function in db/db diabetic obese mice. Obesity (Silver Spring) 2009;17:262-268.
121. Borradaile NM, Han X, Harp JD, Gale SE, Ory DS, Schaffer JE. Disruption of endoplasmic reticulum structure and integrity in lipotoxic cell death. J Lipid Res 2006;47: 2726-2737. (Pubitemid 44936086)
122. Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D et al. The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005;90:4145-4150. (Pubitemid 41058189)
123. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006;17:4-12.
124. Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H et al. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 2003; 108:2460-2466. (Pubitemid 37444406)
125. Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2005;2:536-543. (Pubitemid 41670345)
126. Kremen J, Dolinkova M, Krajickova J, Blaha J, Anderlova K, Lacinova Z et al. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab 2006;91:4620-4627. (Pubitemid 44833447)